Medicus Pharma Partners With Gorlin Syndrome Alliance to Expand Access to SKINJECT
PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) has entered a strategic collaboration with the Gorlin Syndrome Alliance (GSA) to advance compassionate access to SKINJECT™, its investigational doxorubicin-containing microneedle therapy …
Medicus Pharma Partners With Gorlin Syndrome Alliance to Expand Access to SKINJECT Read More